Oncogenic osteomalacia

Common Name(s)

Oncogenic osteomalacia

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Oncogenic osteomalacia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Oncogenic osteomalacia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Oncogenic osteomalacia" returned 31 free, full-text research articles on human participants. First 3 results:

[Oncogenic osteomalacia. Report of two cases].
 

Author(s): Fernando Jerkovich, Daniel Moncet, Silvia Babini, Jorge A Zoppi, Fabiana Graciolli, Beatriz Oliveri

Journal: Medicina (B Aires). 2015 ;75(1):37-40.

 

Oncogenic osteomalacia is a rare disease. It is caused by a tumor that produces fibroblast growth factor 23, a hormone that decreases the tubular phosphate reabsorption and impairs renal hydroxylation of vitamin D. This leads to hyperphosphaturia with hypophosphatemia and low calcitriol ...

Last Updated: 1 Feb 2015

Go To URL
Oncogenic osteomalacia caused by phosphaturic mesenchymal tumours in the proximal and shaft of the tibia: a case report.
 

Author(s): Kongkit Pithankuakul, Tanaporn Ratanasuwan, Voranuch Thanakit, Bhasanan Sukhantanak, Piya Kiatisevi

Journal: J Orthop Surg (Hong Kong). 2014 Aug;22(2):257-62.

 

Oncogenic osteomalacia is caused by a small mesenchymal tumour characterised by phosphaturia, hypophosphatemia, decreased serum vitamin D3 level, and osteomalacia. Phosphaturic mesenchymal tumour of the mixed connective tissue type (PMTMCT) is the commonest subtype and usually involves ...

Last Updated: 28 Aug 2014

Go To URL
Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma.
 

Author(s): David E Leaf, Renata C Pereira, Hasan Bazari, Harald J├╝ppner

Journal: J. Clin. Endocrinol. Metab.. 2013 Mar;98(3):887-91.

 

Oncogenic osteomalacia, a paraneoplastic syndrome associated with hypophosphatemia due to increased urinary phosphate excretion, is caused by excessive synthesis and secretion of fibroblast growth factor 23 (FGF23), a phosphaturic hormone that is normally produced by osteocytes. Most ...

Last Updated: 8 Mar 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Oncogenic osteomalacia" returned 3 free, full-text review articles on human participants. First 3 results:

[Oncogenic osteomalacia and its symptoms: hypophosphatemia, bone pain and pathological fractures].
 

Author(s): Sonia Kaniuka-Jakubowska, Wojciech Biernat, Krzysztof Sworczak

Journal:

 

Oncogenic osteomalacia (OOM) is a rare paraneoplastic syndrome induced by tumor produced phosphaturic factors, i.e. phosphatonins. The disorder is characterized by renal tubular phosphate loss, secondary to this process hypophosphatemia and defective production of active form of vitamin ...

Last Updated: 27 Aug 2012

Go To URL
Dual paraneoplastic syndromes: small cell lung carcinoma-related oncogenic osteomalacia, and syndrome of inappropriate antidiuretic hormone secretion: report of a case and review of the literature.
 

Author(s): Ekamol Tantisattamo, Roland C K Ng

Journal: Hawaii Med J. 2011 Jul;70(7):139-43.

 

Acquired isolated renal phosphate wasting associated with a tumor, known as oncogenic osteomalacia or tumor-induced osteomalacia, is a rare paraneoplastic syndrome caused by overproduction of fibroblast growth factor 23. Oncogenic osteomalacia is usually associated with benign mesenchymal ...

Last Updated: 2 Sep 2011

Go To URL
Oncogenic osteomalacia: a clinicopathologic study of 17 bone lesions.
 

Author(s): Y K Park, K K Unni, J W Beabout, S F Hodgson

Journal: J. Korean Med. Sci.. 1994 Aug;9(4):289-98.

 

Oncogenic osteomalacia is an unusual and rare clinicopathologic syndrome characterized by mesenchymal tumors that apparently produce osteomalacia and biochemical abnormalities consisting of hypophosphatemia, normocalcemia, and increased levels of alkaline phosphatase. We collected ...

Last Updated: 13 Mar 1995

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia
 

Status: Recruiting

Condition Summary: Oncogenic Osteomalacia; Mesenchymal Tumor

 

Last Updated: 13 Jan 2015

Go to URL

Last Updated: 5 Jan 2015

Go to URL
Study of KRN23 in Adult Subjects With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)
 

Status: Recruiting

Condition Summary: Tumor Induced Osteomalacia (TIO); Epidermal Nevus Syndrome (ENS)

 

Last Updated: 15 Apr 2015

Go to URL